Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The diabetic neuropathies.

Clifton Gooch1, David Podwall

  • 1Electromyography Laboratory, Columbia University College of Physicians and Surgeons, Columbia Presbyterian Medical Center, 710 West 168th Street, 13th Floor, New York, NY 10032, USA. clg33@columbia.edu

The Neurologist
|November 3, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and Effectiveness of Eculizumab throughout Three Pregnancies in a Patient with Refractory Generalized Myasthenia Gravis: A Case Report.

Case reports in neurology·2025
Same author

Respiratory Strength Training in Amyotrophic Lateral Sclerosis: A Double-Blind, Randomized, Multicenter, Sham-Controlled Trial.

Neurology·2023
Same author

Therapies, Research Funding, and Racial Diversity in Essential Tremor: A Systematic Review of the Literature.

Movement disorders clinical practice·2022
Same author

Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design.

Neurology. Clinical practice·2021
Same author

Impact of subcutaneous immunoglobulin on quality of life in patients with chronic inflammatory demyelinating polyneuropathy previously treated with intravenous immunoglobulin.

Muscle & nerve·2021
Same author

Eculizumab during Pregnancy in a Patient with Treatment-Refractory Myasthenia Gravis: A Case Report.

Case reports in neurology·2021

Diabetic neuropathy, a common complication of diabetes, is often misdiagnosed and undertreated. Early recognition and comprehensive management are crucial for reducing patient suffering and healthcare costs.

Area of Science:

  • Neurology
  • Endocrinology
  • Diabetology

Background:

  • Diabetes is the leading cause of neuropathy in the US, causing significant morbidity, mortality, and healthcare expenses.
  • Understanding diabetic neuropathy's pathophysiology has advanced, revealing multiple nerve injury mechanisms.

Purpose of the Study:

  • To review the current understanding of diabetic neuropathies.
  • To highlight the importance of accurate diagnosis and effective treatment.

Main Methods:

  • Review of recent advances in diabetes basic science.
  • Analysis of identified mechanisms of nerve injury in diabetes.
  • Examination of various clinical presentations of diabetic neuropathy.

Main Results:

Related Experiment Videos

  • Multiple potential mechanisms for diabetic nerve injury identified, including polyol pathway, oxidative stress, advanced glycosylation end products, and vascular insufficiency.
  • Diabetic neuropathy presents in diverse forms beyond distal symmetric neuropathy, often leading to misdiagnosis.
  • Effective pharmacologic agents are emerging for painful diabetic neuropathy management.

Conclusions:

  • Diabetic neuropathies are prevalent but frequently misdiagnosed and inadequately treated.
  • Understanding disease mechanisms and clinical recognition are vital for effective management.
  • Appropriate primary and symptomatic treatments can significantly decrease associated morbidity and mortality.